We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.

July 18, 2019

Podcast #4: The World of Pharma and Digital Health: Pill, Pill Plus, Plus?

Commentary
Chandana Fitzgerald
A long journey from Ukraine to New Jersey, Eugene Borukhovich had explored the entrepreneur in him during his younger college days - raking in the moolah with a ‘multi dimensional marketing’ idea prior to the dot com boom. However, this failed to satisfy his hunger for impact. Fast forward many different jobs including Metco and Health 2.0 that taught him valuable lessons he uses today, Eugene has leveraged his skills in technology, business and education to build his healthcare career. 

It’s a whirlwind discussion as he unveils his thoughts on the American PBM model, on changing dynamics (moving from one who wanted to seek out large companies to one who gets seeked out now), innovative pharma companies, margins on digital health assets, his favorite start-ups and more!

As Eugene would describe it, ‘’one dark night in Berlin’’, he met the founder of Grants for Apps (G4A) and decided to join them. The G4A Program incubates start-ups that Bayer helps shape into tangible, meaningful products and companies (helping them with everything from receiving investment, to finding the right partners for R&D or commercialization) . The early stage accelerator that started in Berlin has since spread through franchises across the globe, spearheaded by passionate individuals within Bayer. His favourite start up from last year’s cohort is Kinaptic that does muscle memory training for stroke rehab using augmented reality. 

We simply had to ask - Is Pharma building a brand new franchise with these digital assets? The jury is still out. With a multitude of possibilities - just pill, pill plus, just ‘plus’. There are critical questions to be answered, esp in relation to profitability and margins that may help understand what bets pharma will place  - how will existing drug therapies compare with digital therapies? Eugene may not have all the answers, but he certainly leaves us with enough food for thought. As a pharmaceutical company, the one to succeed in absorbing this new identity as a tech-enabled drug maker will be the one who learns the quickest, makes changes the quickest and show significant outcomes. 

If not for this kick ass job, you would find Eugene with his wifey tag teaming on her health coaching initiatives to help people live healthier and longer. Sweet answer for a Russian six footer. 

Episode #4 Eugene Borukhovich

Available now on Spotify, iTunes, Stitcher and Castbox

About Eugene: Eugene Borukhovich is a serial intra and entrepreneur currently serving as a Global Head of Digital Health (G4A) at Bayer. He is also an Entrepreneur in Residence at Personal Health Solutions (PHS) Capital, as well as an advisor to numerous digital health startups. Eugene enjoys mentoring startups and an avid blogger about innovation, digital health and startups. He can be found at @HealthEugene or HealthEugene.com

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

We can provide an introduction on your behalf so that you can contact them directly with any questions/queries on this topic. Simply click on the link below to request an introduction.

Request an Introduction

Ready to read more? HealthXL members can access the full peak of the report on the HealthXL Community Hub.

Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)
Digital Therapeutics (DTx)

Masterclass: Designing for Privacy: GDPR in Digital Health

17th October 2023 @ 11:00AM EDT
Data privacy serves first and foremost to protect patients, and getting it wrong can cost digital health companies and their partners in life sciences dearly.
Featuring
Elena Ames
Elena Ames
Data Privacy Officer, BrightInsight
Featuring
Elena Ames
Elena Ames
Data Privacy Officer, BrightInsight

Are you a HealthXL Member? See the Full Report Here

Non-HealthXL Member? You can purchase the report HERE

HealthXL Digital Health Meetings

Want to join the discussion now?

Join our Digital Health Meetings and take a deep dive for 75 minutes into topics like digital therapeutics, patient support, telehealth, clinical trials, dermatology and many more. These Meetings are not regular webinars: No audience, no recording and no hiding behind a screen. You actively participate in a discussion to solve your present challenges and design the future of digital health. And with a free account on our Community Hub, you stay connected and up-to-date on the latest news and insights, allowing you to fully immerse yourself in the topic before, during and after.

Telemedicine & Virtual Care Delivery
28th September 2023 @ 11:00am EDT

HealthXL Webinar: Rethinking the Medical Affairs Role in the Age of Digital Health

Digital health technologies enable strategic touchpoints with patients and healthcare practitioners, and generate a wealth of real world data. Pharmaceutical companies and their medical affairs teams are yet to fully tap into the potential and opportunities of technology powered patient journeys.



Alex Condoleon
Featuring
Alex Condoleon
Chief Medical Affairs Officer of Global Medical Omnichannel and Digital Customer Solutions, Pfizer
Digital Health Meeting
3rd October @ 11:00am EDT

Does AI Guarantee ROI?

The buzz surrounding AI's role in healthcare is undeniable. Yet, amidst these discussions, a key question remains: Where should AI be harnessed to truly optimize return-on-investment (ROI)?


Featuring
Digital Health Meeting
4th October @ 11:00am

Enhancing Patient Experiences with Data-Driven Insights

In the modern healthcare landscape, the importance of leveraging data-driven insights to enhance patient experiences cannot be overstated. Pharmaceutical companies need to connect with patients because it can bring about big changes in how healthcare is provided

Featuring
5th October @ 11:00am EDT

HealthXL Webinar: The New Frontier of High-Tech and High-Touch in Patient Support Programs

Despite an ongoing push towards more integrated healthcare, there are still many gaps that exist between patients, providers, and pharma.
Eugene Borukhovich
Featuring
Eugene Borukhovich
COO & Co-Founder of YourCoach.Health

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

We cannot guarantee that the content will display correctly while using Internet Explorer. To have the best browsing experience, please upgrade to Microsoft Edge, Google Chrome or Safari.